𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aggressive third-generation chemotherapy does not improve survival compared with standard regimens in people with intermediate or high grade non-Hodgkin's lymphoma

✍ Scribed by Nozomi Niitsu

Book ID
114483789
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
174 KB
Volume
2
Category
Article
ISSN
1363-4054

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Initial high dose chemotherapy plus auto
Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma: Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.
✍ Axel Glasmacher πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 245 KB
High dose therapy and autologous stem ce
High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325
πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science 🌐 English βš– 83 KB